These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26049673)

  • 1. Long-acting injectable versus daily oral antipsychotic treatment trials in schizophrenia: pragmatic versus explanatory study designs.
    Bossie CA; Alphs LD; Correll CU
    Int Clin Psychopharmacol; 2015 Sep; 30(5):272-81. PubMed ID: 26049673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia.
    Alphs L; Schooler N; Lauriello J
    Schizophr Res; 2014 Jul; 156(2-3):228-32. PubMed ID: 24842538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and rationale of the Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study: a novel comparative trial of once-monthly paliperidone palmitate versus daily oral antipsychotic treatment for delaying time to treatment failure in persons with schizophrenia.
    Alphs L; Mao L; Rodriguez SC; Hulihan J; Starr HL
    J Clin Psychiatry; 2014 Dec; 75(12):1388-93. PubMed ID: 25375367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.
    Biagi E; Capuzzi E; Colmegna F; Mascarini A; Brambilla G; Ornaghi A; Santambrogio J; Clerici M
    Adv Ther; 2017 May; 34(5):1036-1048. PubMed ID: 28382557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA].
    Teitelbaum A; Kodesh A
    Harefuah; 2019 Jul; 158(7):453-457. PubMed ID: 31339245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.
    Kirson NY; Weiden PJ; Yermakov S; Huang W; Samuelson T; Offord SJ; Greenberg PE; Wong BJ
    J Clin Psychiatry; 2013 Jun; 74(6):568-75. PubMed ID: 23842008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.
    Kishimoto T; Sanghani S; Russ MJ; Marsh AN; Morris J; Basu S; John M; Kane JM
    Int Clin Psychopharmacol; 2017 May; 32(3):161-168. PubMed ID: 28181959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Outcomes in Nonacute Patients With Schizophrenia Treated With Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics.
    Petric PS; Teodorescu A; Miron AA; Manea MC; Ifteni P
    Am J Ther; 2024 May-Jun 01; 31(3):e219-e228. PubMed ID: 38691662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial.
    Green AI; Brunette MF; Dawson R; Buckley P; Wallace AE; Hafez H; Herz M; Narasimhan M; Noordsy DL; O'Keefe C; Sommi RW; Steinbook RM; Weeks M
    J Clin Psychiatry; 2015 Oct; 76(10):1359-65. PubMed ID: 26302441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Converting oral to long-acting injectable antipsychotics: a guide for the perplexed.
    Meyer JM
    CNS Spectr; 2017 Dec; 22(S1):14-28. PubMed ID: 29350127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial.
    Foster A; Buckley P; Lauriello J; Looney S; Schooler N
    J Clin Psychopharmacol; 2017 Oct; 37(5):595-599. PubMed ID: 28806390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.
    Doshi JA; Pettit AR; Stoddard JJ; Zummo J; Marcus SC
    J Clin Psychopharmacol; 2015 Aug; 35(4):442-6. PubMed ID: 26075492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial methodology to assess the efficacy/effectiveness of long-acting antipsychotics: Randomized controlled trials vs naturalistic studies.
    Fagiolini A; Rocca P; De Giorgi S; Spina E; Amodeo G; Amore M
    Psychiatry Res; 2017 Jan; 247():257-264. PubMed ID: 27936437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting injectable antipsychotics: evidence of effectiveness and use.
    Manchanda R; Chue P; Malla A; Tibbo P; Roy MA; Williams R; Iyer S; Lutgens D; Banks N
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):5S-13S. PubMed ID: 23945067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes.
    Barnes TR; Drake RJ; Dunn G; Hayhurst KP; Jones PB; Lewis SW
    Br J Psychiatry; 2013 Sep; 203(3):215-20. PubMed ID: 23888001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting injectable antipsychotics in early psychosis: a literature review.
    Emsley R; Chiliza B; Asmal L; Mashile M; Fusar-Poli P
    Early Interv Psychiatry; 2013 Aug; 7(3):247-54. PubMed ID: 23342964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of offering long-acting antipsychotic therapies: a preliminary discourse analysis of psychiatrist recommendations for injectable therapy to patients with schizophrenia.
    Weiden PJ; Roma RS; Velligan DI; Alphs L; DiChiara M; Davidson B
    J Clin Psychiatry; 2015 Jun; 76(6):684-90. PubMed ID: 25939027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry.
    Kane JM; Kishimoto T; Correll CU
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S37-41. PubMed ID: 23849151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.